Prescribing info for lecanemab features a boxed warning about opportunity threats associated with ARIA. Suitable use suggestions explore strategies to attenuate ARIA possibility, as does AAN advice. The extension analyze also evaluated CLARITY Advertisement participants who experienced a delayed start (people that switched from placebo to lecanemab following the Main https://testingfordementianearme54432.luwebs.com/35105342/the-ultimate-guide-to-alzheimer-s-dementia-test